载有奎尔的框架核酸:通过蛋白激酶B/血氧化酶-1通路保护视网膜神经血管单元
Yili Jin1, Xiaodi Zhou1, Limei Chen1
1State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou 510060, China.
ACS nano
|September 13, 2024
概括
这项研究引入了一种新的DNA纳米复合物,tFNAs-QUE,用于治疗缺血性视网膜疾病. 该复合物有效地抑制异常的血管生长,并通过激活特定的细胞通路来保护视力.
科学领域:
- 眼科医生 眼科 眼科
- 纳米医学是一种纳米医学.
- 分子生物学分子生物学
背景情况:
- 视网膜神经血管疾病是全球导致失明的主要原因之一.
- 病理性新血管化涉及视网膜中异常的血管生长.
- 目前的治疗方法在有效性和特异性方面面临挑战.
研究的目的:
- 开发一种用于治疗缺血性视网膜疾病的新型药物输送系统.
- 研究载入四面体框架核酸 (tFNA) 的奎尔丁 (QUE) 的治疗潜力.
- 为了阐明tFNAs-QUE纳米复合物的潜在分子机制.
主要方法:
- 使用tFNA作为QUE的载体制造一种脱氧核糖核酸 (DNA) 纳米复合物 (tFNAs-QUE).
- 在体内和体外实验中评估tFNAs-QUE对视网膜新血管化的影响.
- 对AKT/Nrf2/HO-1信号通路激活的分析.
主要成果:
- 这种tFNAs-QUE纳米复合物有效地抑制了病理性新血管化.
- 它减少了视网膜的非 perfusion 区域,并保护了视网膜的神经元.
- 该纳米复合物选择性地提高了AKT/Nrf2/HO-1通路的调节,显示出抗氧化和抗血管性作用.
结论:
- tFNAs-QUE是一种有前途的治疗策略,用于缺血性视网膜疾病.
- 这种小分子载荷机制为治疗视力丧失提供了一种新的方法.
- 准AKT/Nrf2/HO-1通路对于管理视网膜新血管化至关重要.
相关概念视频
Photoreceptors and Visual Pathways
5.9K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
5.9K
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K


